Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Oncotarget|February 5, 2011
Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndromeEmmanuel Raffoux, Audrey Cras, Christian Recher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve DiseaseNicolas Gendron, Mickael Rosa, Adeline Blandinieres, et al.
Stem Cell Reviews and Reports|November 18, 2020
Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 CellsCoralie L Guerin, Léa Guyonnet, Guillaume Goudot, et al.
Haematologica|March 18, 2017
Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banksHanadi Rafii, Françoise Bernaudin, Helene Rouard, et al.
Bone Marrow Transplantation|May 15, 2021
Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)Hanadi Rafii, Federico Garnier, Annalisa Ruggeri, et al.
Critical Care (London, England)|February 22, 2022
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trialAntoine Monsel, Caroline Hauw-Berlemont, Miryam Mebarki, et al.
Stem Cell Research & Therapy|April 18, 2024
Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of lifeAlexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, et al.
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Pageof 5